Alpha Tau Medical Ltd (DRTS) — Capital Reinvestment Ratio

Latest as of June 2021: 0.23x

Alpha Tau Medical Ltd (DRTS) has a Capital Reinvestment Ratio of 0.23x as of June 2021, meaning it reinvests 0% of its operating cash flow ($2.65 Million) in capital expenditures ($609.00K). See Alpha Tau Medical Ltd (DRTS) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.23x
Capex / Operating Cash Flow

Operating Cash Flow

$2.65 Million
USD

Capital Expenditures

$609.00K
USD

Data as of

Jun 2021
Most recent filing

Annual Capital Reinvestment Ratio for Alpha Tau Medical Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Alpha Tau Medical Ltd from None to None. For live market cap and broader valuation context, see Alpha Tau Medical Ltd (DRTS) total market value.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow